Related Experiment Video
Updated: Jun 21, 2026
Assessing the Accuracy of Fitness Smartwatch Data for Cardiovascular and Physical Activity Monitoring: A Validation Study in Digital Health
Published on: February 21, 2025
External validity of the cardiovascular health study: a comparison with the Medicare population
Lisa D DiMartino1, Bradley G Hammill, Lesley H Curtis
1Center for Clinical and Genetic Economics, Duke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina 27715, USA.
Insights
The Cardiovascular Health Study (CHS) cohort is similar to Medicare beneficiaries in health conditions but has lower mortality, possibly due to selection bias. Findings may not apply to absolute rates in the general Medicare population.
Area of Science:
- Gerontology
- Epidemiology
- Public Health
Background:
- The Cardiovascular Health Study (CHS) is a population-based prospective cohort study.
- It has identified major risk factors for cardiovascular disease and stroke in the elderly.
Purpose of the Study:
- To assess the external validity of the Cardiovascular Health Study (CHS).
Main Methods:
- Comparison of the CHS cohort with a national cohort of Medicare beneficiaries.
- Inclusion of Medicare beneficiaries from CHS geographic regions.
- Analysis of demographic, administrative, comorbidity, resource use, and mortality data.
Main Results:
- The CHS cohort was older, with more men and African American participants compared to Medicare cohorts.
- CHS participants had lower mortality rates (over 40% at 1 year, 25% at 5 years, 15% at 10 years).
- Comorbid conditions and healthcare resource utilization were similar between CHS and Medicare cohorts.
Conclusions:
- The CHS cohort is comparable to the Medicare population regarding comorbidities and resource use.
- Lower mortality in CHS may be attributed to recruitment strategy or volunteer bias.
- Absolute rates from CHS may not be generalizable to the entire Medicare population, but relative risks are likely valid.
Background:
The Cardiovascular Health Study (CHS), a population-based prospective cohort study, has been used to identify major risk factors associated with cardiovascular disease and stroke in the elderly.
Objective:
To assess the external validity of the CHS.
Research Design:
Comparison of the CHS cohort to a national cohort of Medicare beneficiaries and to Medicare beneficiaries residing in the CHS geographic regions.
Subjects:
CHS participants and a 5% sample of Medicare beneficiaries.
Measures:
Demographic and administrative characteristics, comorbid conditions, resource use, and mortality.
Results:
Compared with both Medicare cohorts, the CHS cohort was older and included more men and African American participants. CHS participants were more likely to be enrolled in Medicare managed care than beneficiaries in the national Medicare cohort. Compared with the Medicare cohorts, mortality in the CHS was more than 40% lower at 1 year, approximately 25% lower at 5 years, and approximately 15% lower at 10 years. There were minimal differences in comorbid conditions and health care resource use.
Conclusion:
The CHS cohort is comparable with the Medicare population, particularly with regard to comorbid conditions and resource use, but had lower mortality. The difference in mortality may reflect the CHS recruitment strategy or volunteer bias. These findings suggest it may not be appropriate to project absolute rates of disease and outcomes based on CHS data to the entire Medicare population. However, there is no reason to expect that the relative risks associated with physiologic processes identified by CHS data would differ for nonparticipants.
Related Concept Videos
01:23Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:20Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:29Assessment of the Cardiovascular System II: Inspection
Head and Neck
01:21Imaging Studies for Cardiovascular System IV: CMRI